DEBRA TAFT: Open Payments
NPI 1639431810 · SOMERSET, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,043 in 54 payments from 22 companies in 2025. Trend: 2023 $741 · 2024 $1,634 · 2025 $2,043
Food & beverage: $1,899Education: $143
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $243 |
| Astellas Pharma US Inc | 5 | $205 |
| Merck Sharp & Dohme LLC | 8 | $188 |
| Caris MPI, Inc. | 4 | $166 |
| Solventum Corporation | 1 | $160 |
| Exelixis Inc. | 2 | $151 |
| Regeneron Healthcare Solutions, Inc. | 1 | $127 |
| JAZZ PHARMACEUTICALS INC. | 1 | $115 |
| Dendreon Pharmaceuticals LLC | 1 | $114 |
| PFIZER INC. | 8 | $107 |
Products named: Xtandi, KEYTRUDA, MI CANCER SEEK, V.A.C. VERAFLO, CABOMETYX, LIBTAYO, OPDIVO, REBLOZYL.
Industry payments across KY — which companies pay providers there.
